Clinical Trials

Clicking a link below will scroll the
page down to the relevant section

Lung Cancer
Mesothelioma

Lung Cancer

top

A Phase I/II Study of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma Who Have Developed Resistance to Erlotinib Alone
Riely, Gregory, MD, PhD

[Protocol 08-055]
A Phase I/II Study of Obatoclax Mesylate (GX15-070MS) Plus Topotecan in Patients with Relapsed Small Cell Lung Carcinoma
Krug, Lee, MD

[Protocol 07-082]
A Phase II Study of Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer Patients with EGFR-Activating Mutations
Rizvi, Naiyer, MD

[Protocol 09-026]
A Phase II Study of Erlotinib and Chemotherapy for Operable Stage IB-IIIA Non-Small Cell Lung Cancer Patients Who Are Nonsmokers or Light Smokers
Rizvi, Naiyer, MD

[Protocol 07-103]
A Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer
Pietanza, M. Catherine, MD

[Protocol 08-065]
A Phase II Trial of Dasatinib in Patients with Lung Adenocarcinoma with Acquired Resistance to Erlotinib or Gefitinib
Miller, Vincent, MD

[Protocol 06-143]
A Phase II Trial of Erlotinib in Patients with Resected, Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor Mutations
Azzoli, Christopher, MD

[Protocol 08-152]
A Phase II Trial of Paclitaxel, Pemetrexed, and Bevacizumab in Patients with Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects, and Automated Response Assessment
Pietanza, M. Catherine, MD

[Protocol 08-109]
A Phase Ib Study of MDX-1106 in Patients with Selected Advanced or Recurrent Malignancies
Wolchok, Jedd, MD, PhD

[Protocol 09-012]
A Phase Ib/IIa Study of AV-951 in Patients with Advanced Non-Small Cell Lung Cancer
Rizvi, Naiyer, MD

[Protocol 08-144]
A Pilot Study of Docetaxel plus Vinorelbine as Adjuvant Chemotherapy for Patients with Resected Non-Small Cell Lung Cancer
Azzoli, Christopher, MD

[Protocol 07-178]
A Pilot Trial Assessing the Safety and Immunogenicity of the GI-4000 Vaccine as Consolidation Therapy after Curative Treatment for Stage I-III Non-Small Cell Lung Cancers with K-ras Mutations
Azzoli, Christopher, MD

[Protocol 07-149]
A Randomized Study Comparing Aflibercept versus Placebo in Patients Treated with Second-Line Docetaxel after Failure of One Platinum-Based Therapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Pietanza, M. Catherine, MD

[Protocol 08-075]
A Study of Deforolimus (MK-8669) in Non-Small Cell Lung Cancer Patients with KRAS Mutations
Riely, Gregory, MD, PhD

[Protocol 09-047]
Health Communication in Families
Ostroff, Jamie, PhD

[Protocol 03-088]
Improving Functional Outcomes in Patients with Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging
Kraus, Dennis, MD

[Protocol 05-036]
Multimodality Treatment for Patients with Resectable Non-Small Cell Lung Cancer (BEACON Study: BEvacizumab And Chemotherapy for Operable NSCLC)
Rizvi, Naiyer, MD

[Protocol 05-052]
Phase II Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients Age 65 and Older
Small, Trudy, MD

[Protocol 08-005]
Physical Activity Intervention for Lung Cancer Survivors
Ostroff, Jamie, PhD

[Protocol 08-067]
Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Lobectomy versus Thoracotomy and Lobectomy
Park, Bernard, MD

[Protocol 05-006]
Screening for Depression in Lung Cancer Patients
Passik, Steven, PhD

[Protocol 06-038]
Support Needs and Preferences of Family Caregivers of Lung Cancer Patients
Ostroff, Jamie, PhD

[Protocol 09-104]
The Use of Breathing Synchronized PET/CT Imaging in the Detection and Quantification of FDG Uptake in Lung Nodules
Schoder, Heiko, MD

[Protocol 04-025]

Mesothelioma

top

A Phase III Trial of Oral Suberoylanilide Hydroxamic Acid (L-001079038) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy
Krug, Lee, MD

[Protocol 05-095]
Phase II Study of CBP501, Pemetrexed, and Cisplatin in Chemotherapy-Naïve Patients with Malignant Pleural Mesothelioma
Krug, Lee, MD

[Protocol 08-082]
Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
Rosenzweig, Kenneth, MD

[Protocol 08-053]

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2009 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org